Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
Clinical trial NCT01247922 · TERMINATED
Trial details
- NCT number
- NCT01247922
- Sponsor
- OSI Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-23
- Primary completion
- 2012-09-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.